
Published Date: January 3, 2026
Updated Date: January 3, 2026
What is a Pharmacovigilance Manager in HealthTech?
A Pharmacovigilance Manager in HealthTech is accountable for ensuring a company detects, evaluates, and acts on safety risks linked to how patients use a product that has medicinal impact, whether that's a digital therapy, a medication-enabled service, or a platform that influences prescribing, dosing, adherence, or monitoring. In plain terms: they own the safety surveillance nerve centre that turns real-world signals into decisions the business can stand behind.
This role exists because HealthTech products can change clinical decisions at scale, quickly. When that happens, safety risk isn't abstract: it shows up as side effects, misuse, missed contraindications, interactions not surfaced, or vulnerable users being put into unsafe pathways. A Pharmacovigilance Manager ensures the company can prove it is actively monitoring for harm, meeting reporting obligations where applicable, and taking proportionate action without waiting for a crisis.
Ownership comes first. A strong Pharmacovigilance Manager is the person the organisation relies on to say: "This is our current benefit–risk position, this is what we know, this is what we don't, and this is what we're doing next." Methods, tools, and processes matter, but they sit under that accountability.
🔍 How this role differs in HealthTech
In many tech sectors, risk management is mostly about uptime, fraud, or data breaches. In HealthTech, the stakes are more direct: product decisions can alter care, affect medication exposure, and create patient harm if the system behaves unexpectedly or if users behave unexpectedly in response to the system.
That changes the operating model. A Pharmacovigilance Manager in HealthTech works in a world where evidence is incomplete, signals are noisy, and changes must be made under regulatory, clinical, and reputational constraints. Data sensitivity is higher (health data, special category data), and the right decision often involves balancing patient safety, clinical workflow, user experience, commercial commitments, and what can be justified to regulators or partners.
Organisationally, the role often sits close to Regulatory Affairs, Quality, Medical or Clinical Safety, but needs day-to-day reach into Product, Data, Customer Operations, and Partnerships. In smaller HealthTechs, it can be a bridge role: building the safety system while simultaneously advising leadership on what the company can safely scale.
🎯 Core responsibilities in HealthTech
Day to day, the Pharmacovigilance Manager is accountable for whether safety information is being captured consistently, assessed correctly, and escalated quickly enough to prevent repeat harm. They set the expectations for how adverse events, side effects, and safety complaints are identified across channels (app flows, customer support tickets, clinician partners, and sometimes third-party vendors) then ensure the organisation can transform that intake into defensible safety decisions.
A big part of the job is judgement under constraints. You rarely get perfect data: reports may be incomplete, timelines may be tight, and operational teams may be stretched. The Pharmacovigilance Manager decides what constitutes a safety signal worth formal investigation, what needs immediate containment, and what can be monitored with defined thresholds. They also own the trade-offs between speed and certainty: moving fast enough to protect users whilst maintaining the discipline needed for auditability and compliance.
In practice, they spend as much time aligning humans as managing processes: negotiating responsibilities with clinical leadership, pushing for product changes that reduce risk, challenging metrics that hide safety issues, and preparing the company to respond calmly to external scrutiny. When things go wrong, they help the business respond in a way that is clinically sound, regulator-ready, and operationally feasible.
🧩 Skills and competencies for HealthTech
Core Skill | HealthTech specific requirement | Reason or Impact |
|---|---|---|
Safety judgement under uncertainty | Ability to make proportionate decisions when data is incomplete, user behaviour is variable, and clinical context is messy | Prevents both under-reaction (patient harm) and over-reaction (unnecessary disruption, loss of trust, avoidable product freezes) |
Regulatory and compliance ownership | Comfort operating with formal obligations, inspections, and documentary expectations whilst the product iterates | Keeps the company scalable with partners and regulators, and reduces compliance debt that blocks growth later |
Cross-functional influence | Authority without relying on hierarchy, especially across Product, Data, Ops, and Clinical | Safety fixes often require trade-offs; influence ensures risk controls actually land in the product and operations |
Signal detection mindset | Thinking in patterns and weak signals across disparate data sources (support, app events, clinical feedback, third parties) | Improves early detection of emerging risks before they become systemic incidents |
Clear escalation and decision framing | Ability to translate safety risk into decisions leadership can take quickly, with options and consequences | Speeds up response time and reduces paralysis during safety events |
Audit-ready communication | Writing and communicating in a way that is traceable, consistent, and defensible | Protects the organisation during partner due diligence, regulator queries, and internal governance reviews |
Vendor and partner oversight | Managing outsourced PV operations or shared responsibilities with clinical networks and service partners | Ensures safety accountability doesn't get dropped between organisations, especially in hybrid delivery models |
💷 Salary ranges in UK HealthTech
Pharmacovigilance compensation in HealthTech is shaped less by pure years of experience and more by how much risk the person truly owns. The biggest drivers are: whether the company holds regulated responsibilities directly, whether you're building the safety system from scratch versus running a mature function, the criticality of the product (patient population and potential harm), leadership scope (team size, portfolio size, partner exposure), on-call or out-of-hours expectations, and location.
Experience level | Estimated annual salary range | What drives compensation |
Junior | London & South East: £35,000–£45,000 | Usually supports case intake, triage, process adherence, and documentation under close supervision; higher pay when the role includes direct partner-facing work or complex products |
Mid-level | London & South East: £45,000–£60,000 | More independent ownership of workflows, quality checks, and stakeholder coordination; pay rises with portfolio breadth and responsibility for end-to-end reporting timelines |
Senior | London & South East: £60,000–£80,000 | Owns investigations, signal assessment, governance forums, and changes to risk controls; higher ranges when the role is the primary safety authority for a product line or regulated partner network |
Lead | London & South East: £75,000–£100,000 | Leads the function or a major programme, sets strategy, manages audits/inspections readiness, and drives cross-company change; compensation increases with team leadership, vendor oversight, and organisational accountability |
Head / Director | London & South East: £95,000–£140,000 | Accountable for the pharmacovigilance system and safety governance across products/markets; higher pay when the role carries named accountability, complex partner ecosystems, and high incident-response expectations |
Typical add-ons vary by company maturity and risk profile. Many roles include an annual bonus (often modest in earlier-stage HealthTech, more structured in larger organisations), and equity can be meaningful in venture-backed companies, especially at Lead and Head/Director level. On-call or out-of-hours allowances are most common where there is a formal 24/7 safety expectation (for urgent safety escalations, regulator/partner queries, or incident response), and can materially change total compensation when the rota is intense or cover is scarce. Variation is also driven by whether PV operations are in-house versus outsourced, the burden of audits, and how directly revenue depends on safety compliance.
🚀 Career pathways
Entry into Pharmacovigilance Management in HealthTech often starts from drug safety operations, clinical research, regulatory affairs, quality, pharmacy, nursing, or medical-science roles, especially where you've had responsibility for adverse event handling, case review, or safety reporting. Some candidates come from customer operations or clinical support functions inside HealthTech and move into PV by taking ownership of intake quality, escalation pathways, and safety governance.
Progression is less about collecting titles and more about increasing the radius of accountability. Early on, you prove you can run a reliable process; then you prove you can make difficult calls with imperfect information; then you prove you can shape the system itself: governance, partner alignment, audit readiness, vendor oversight, and product-level risk controls.
At the top end, the career becomes about organisational design and trust. You're not only running pharmacovigilance but making it easier for the company to ship safely, scale partnerships, withstand scrutiny, and respond calmly when the real world behaves differently than the roadmap.
❓ FAQ
Do I need to be a pharmacist or clinician to be a Pharmacovigilance Manager in HealthTech?
Not always. Many Pharmacovigilance Managers come from life sciences safety operations or regulatory backgrounds, and succeed by pairing strong PV fundamentals with the ability to influence product and operations. In HealthTech, credibility with clinical stakeholders helps, but the core requirement is ownership of safety decisions and the discipline to run an auditable system.
What will interviewers test that's specific to HealthTech pharmacovigilance?
Expect scenario-based questions about ambiguous safety reports, noisy data, and cross-functional conflict (for example, when product wants speed and safety wants certainty). They'll often probe how you'd set escalation thresholds, how you'd prevent under-reporting across support channels, and how you'd drive changes in a fast-shipping environment without breaking compliance.
Is on-call common for Pharmacovigilance Managers in HealthTech, and what does it look like?
It depends on how the product is delivered and how safety accountability is structured. On-call is more likely when the company must respond rapidly to serious safety events, partner escalations, or formal safety queries, especially outside business hours. In practice, it can range from light "reachable for advice" coverage to a defined rota with strict response expectations.
🔎 Find your next role
If you're looking for your next Pharmacovigilance Manager role in HealthTech, search open positions on Meeveem and compare scope, ownership, and safety accountability, not just the title.
You might also like



